Communities of practice
Malaria is a vector-borne infectious disease that is widespread in tropical and subtropical regions, including parts of the Americas, Asia, and Africa. It causes disease in approximately 400 million people every year and kills between one and three million people every year, mostly young children in Sub-Saharan Africa. Malaria is commonly-associated with poverty, but is also a cause of poverty and a major hindrance to economic development.
27 Jun 2011
With time and trust, partnerships pay off
2 Jun 2010
When interventions are planned, insufficient thought is given as to whether the poorest and most vulnerable members of society will benefit, according to the findings of a new review of the evidence. The reviewers call for more research to assess which infectious disease programmes benefit the poor and to identify the mechanisms that determine “pro-poor effectiveness”.
25 Apr 2011
Under-researched and over-exploited, ages-old natural treatments for symptoms of malaria are critically endangered.
11 Apr 2011
Artemisinin resistance is the single most important threat to global malaria control with the potential to reverse many of the gains made to date. Whether it does may hinge on WHO’s new Global Plan for Artemisinin Resistance Containment (GPARC) and how countries around the world choose to respond.
24 Feb 2011
The latest G-FINDER report says that funding for basic scientific research has increased but finances available for product development have fallen. How can funders determine where the greatest needs lie and work more closely together?
27 Oct 2010
A verbal autopsy study in India has produced an extraordinarily high estimate of the number of people who die from malaria.
18 Jul 2011
New research says the cheap, commonly-used endectocide could dramatically reduce transmission
18 May 2011
P. falciparum’s high polymorphism bodes well for genetic fingerprinting in sub-Saharan Africa. But standardized protocols should be updated to facilitate data comparison between studies.
2 Feb 2011
A synthesis of the evidence by the Department for International Development concludes that we know what works, but the evidence on how best to deliver effective interventions is weaker, often conflicting and context specific.
17 Jan 2011
The appearance of resistance to the key antimalarial artemisinin is one of the greatest concerns facing global health. A call for action from WHO and the Roll BackMalaria partnership now provides a five-point action plan.
Is your organisation working against the infectious diseases of poverty?